Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
Evandro Fei Fang,Yujun Hou,Konstantinos Palikaras,Bryan A. Adriaanse,Jesse S. Kerr,Beimeng Yang,Sofie Lautrup,Mahdi Hasan-Olive,Domenica Caponio,Xiuli Dan,P Rocktäschel,Deborah L. Croteau,Mansour Akbari,Nigel H. Greig,Tormod Fladby,Hilde Nilsen,M Z Cader,Mark P. Mattson,Nektarios Tavernarakis,Nektarios Tavernarakis,Vilhelm A. Bohr,Vilhelm A. Bohr +21 more
TLDR
Evidence that mitophagy is impaired in the hippocampus of AD patients, in induced pluripotent stem cell-derived human AD neurons, and in animal AD models is provided, suggesting that impaired removal of defective mitochondria is a pivotal event in AD pathogenesis and thatMitophagy represents a potential therapeutic intervention.Abstract:
Accumulation of damaged mitochondria is a hallmark of aging and age-related neurodegeneration, including Alzheimer's disease (AD). The molecular mechanisms of impaired mitochondrial homeostasis in AD are being investigated. Here we provide evidence that mitophagy is impaired in the hippocampus of AD patients, in induced pluripotent stem cell-derived human AD neurons, and in animal AD models. In both amyloid-β (Aβ) and tau Caenorhabditis elegans models of AD, mitophagy stimulation (through NAD+ supplementation, urolithin A, and actinonin) reverses memory impairment through PINK-1 (PTEN-induced kinase-1)-, PDR-1 (Parkinson's disease-related-1; parkin)-, or DCT-1 (DAF-16/FOXO-controlled germline-tumor affecting-1)-dependent pathways. Mitophagy diminishes insoluble Aβ1-42 and Aβ1-40 and prevents cognitive impairment in an APP/PS1 mouse model through microglial phagocytosis of extracellular Aβ plaques and suppression of neuroinflammation. Mitophagy enhancement abolishes AD-related tau hyperphosphorylation in human neuronal cells and reverses memory impairment in transgenic tau nematodes and mice. Our findings suggest that impaired removal of defective mitochondria is a pivotal event in AD pathogenesis and that mitophagy represents a potential therapeutic intervention.read more
Citations
More filters
Journal ArticleDOI
Ageing as a risk factor for neurodegenerative disease.
Yujun Hou,Xiuli Dan,Mansi Babbar,Yong Wei,Steen G. Hasselbalch,Deborah L. Croteau,Vilhelm A. Bohr,Vilhelm A. Bohr +7 more
TL;DR: Hallmarks of ageing — genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, stem cell exhaustion and altered intercellular communication — correlate with susceptibility to neurodegenerative disease.
Journal ArticleDOI
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis.
Lianjiu Su,Jiahao Zhang,Hernando Gomez,Raghavan Murugan,Xing Hong,Dongxue Xu,Fan Jiang,Zhiyong Peng,Zhiyong Peng +8 more
TL;DR: This review discussed how ROS propagate lipid peroxidation chain reactions and how the products of lipidperoxidation initiate apoptosis and autophagy in current models, and summarized lipid per oxidation in pathological conditions of critical illness.
Journal ArticleDOI
Synergy between amyloid-β and tau in Alzheimer’s disease
TL;DR: Emerging evidence for an interaction between Aβ and tau during Alzheimer’s disease (AD) progression that challenges the classical linear trajectory model and offers a new perspective on AD pathophysiology and therapy is reviewed.
Journal ArticleDOI
Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
TL;DR: This review will discuss mechanisms underlying mitochondrial dysfunction with a focus on the loss of mitochondrial structural and functional integrity in AD including mitochondrial biogenesis and dynamics, axonal transport, ER-mitochondria interaction, mitophagy and mitochondrial proteostasis.
Journal ArticleDOI
NAD+ metabolism and its roles in cellular processes during ageing
Anthony J. Covarrubias,Anthony J. Covarrubias,Rosalba Perrone,Alessia Grozio,Eric Verdin,Eric Verdin +5 more
TL;DR: Nicotinamide adenine dinucleotide (NAD+) is a coenzyme for redox reactions, making it central to energy metabolism and is also an essential cofactor for non-redox NAD+-dependent enzymes, including sirtuins, CD38 and poly(ADP-ribose) polymerases as discussed by the authors.
References
More filters
Journal ArticleDOI
Sex differences in Alzheimer's disease and other dementias
Carolyn M. Mazure,Joel Swendsen +1 more
TL;DR: It is asserted that, integrated within the portfolio of research proposed by the Commission, a focus on the effect of sex on AD and other dementias is essential to ensure progress in understanding, treatment, and prevention of these disorders.
Journal ArticleDOI
Protecting the mitochondrial powerhouse.
TL;DR: Different quality control pathways maintain mitochondria function including mitochondrial DNA replication and repair, fusion-fission dynamics, free radical scavenging, and mitophagy are reviewed and a strategy towards a treatment for these often untreatable disorders is proposed.
Journal ArticleDOI
Mitophagy in neurodegeneration and aging.
Elayne M. Fivenson,Sofie Lautrup,Nuo Sun,Morten Scheibye-Knudsen,Tinna Stevnsner,Hilde Nilsen,Vilhelm A. Bohr,Vilhelm A. Bohr,Evandro Fei Fang +8 more
TL;DR: An updated mechanistic overview ofMitophagy pathways is provided and potential translational applications of mitophagy‐inducing compounds, such as NAD+ precursors and urolithins are highlighted.
Journal ArticleDOI
Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain
TL;DR: In vivo findings that AICD can contribute to AD pathology independently of Aβ have important therapeutic implications and may explain some observations that are discordant with the amyloid hypothesis.
Journal ArticleDOI
JNK3 Perpetuates Metabolic Stress Induced by Aβ Peptides
Sung Ok Yoon,Dong Ju Park,Jae Cheon Ryu,Hatice Gulcin Ozer,Chhavy Tep,Yong Jae Shin,Tae Hee Lim,Lucia Pastorino,Ajaya J. Kunwar,James C. Walton,Alan H. Nagahara,Kun Ping Lu,Randy J. Nelson,Mark H. Tuszynski,Kun Huang +14 more
TL;DR: AD is revealed as a metabolic disease that is under tight control by JNK3, which induces a translational block by activating AMPK, thereby inhibiting the mTOR pathway and phosphorylates APP at T668, thereby facilitating its endocytosis and subsequent processing.